NSAID Selection and Monitoring for Elderly Patients with Pelvic Fracture

Age‑Related Risk Profile

Patients ≥ 60 years have a markedly increased risk of peptic ulcer disease, gastrointestinal hemorrhage, renal toxicity (including interstitial nephritis and papillary necrosis), and cardiovascular complications when using NSAIDs, according to the National Comprehensive Cancer Network (NCCN) guidelines. [4][5]
The NCCN identifies age > 60 years as a threshold for heightened susceptibility to NSAID‑related renal, gastrointestinal, and cardiac adverse events. [1][2]3

Ketorolac is limited to short‑term use (maximum 5 days) in NCCN clinical recommendations; extending beyond this duration substantially raises adverse‑event risk, especially in older adults. [1][2][3][4]
Naproxen may be continued for the longer course required for pelvic fracture healing because it is not subject to the 5‑day restriction imposed on ketorolac. [1][2]
NCCN advises selecting “any NSAID the patient has previously tolerated,” with ibuprofen (pharmacologically similar to naproxen) preferred before considering ketorolac. [1][3]4

The American Geriatrics Society (JAGS) and the World Society of Emergency Surgery (2024) recommend acetaminophen as first‑line therapy (650–1000 mg every 6 h, ≤ 4 g/24 h) for older trauma patients because of its superior safety profile compared with NSAIDs. [6][7] – Strong recommendation.
If acetaminophen alone is insufficient, adding naproxen is endorsed; NSAIDs are effective for all pain intensities in the short term when not contraindicated (Annals of Oncology, 2012). 8 – Moderate recommendation.
The 2024 World Society of Emergency Surgery guidelines strongly recommend regular intravenous acetaminophen every 6 h as the initial treatment for acute trauma pain in the elderly, with NSAIDs added for severe pain after evaluating potential adverse events. 7 – Strong recommendation.

Prior to NSAID initiation, obtain baseline blood pressure, BUN, creatinine, liver‑function tests (alkaline phosphatase, LDH, AST, ALT), complete blood count, and fecal occult blood testing (NCCN). [2][3]5
Discontinue NSAIDs promptly if any of the following occur: BUN or creatinine doubles, new or worsening hypertension, elevation of liver enzymes above normal, or signs of gastrointestinal bleeding (NCCN). [1][4]
Monitor for gastric upset or nausea; if these develop, consider switching to a selective COX‑2 inhibitor, which has a lower incidence of GI side effects (NCCN). [2][3]

History of peptic ulcer disease or significant alcohol consumption (≥ 2 drinks/day) warrants avoidance of NSAIDs (NCCN). [1][4]
Compromised fluid status or concurrent use of nephrotoxic medications contraindicates NSAID therapy (NCCN). [1][3]
Established cardiovascular disease or concurrent anticoagulant therapy (warfarin, heparin) significantly increases bleeding risk; NSAIDs should be avoided (NCCN). [1][4]5
Thrombocytopenia or any bleeding disorder is a contraindication to NSAID use (NCCN). [1][2]

In high‑risk elderly patients who require NSAIDs, prescribe gastro‑protective agents such as proton‑pump inhibitors or misoprostol (NCCN). [2][3]

UK guidelines (British Journal of Anaesthesia, 2021) recommend a stepwise reduction: first taper opioids, then discontinue NSAIDs, and finally stop acetaminophen, to minimize withdrawal and adverse effects. [9][10] – Strong recommendation.

All facts are derived from cited guideline sources and reflect the strength of recommendation where specified.